Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enanta Pharmaceuticals (ENTA) Preferred Shares (2016)

Enanta Pharmaceuticals' Preferred Shares history spans 2 years, with the latest figure at $158000.0 for Q2 2016.

  • For Q2 2016, Preferred Shares changed N/A year-over-year to $158000.0; the TTM value through Jun 2016 reached $158000.0, changed N/A, while the annual FY2015 figure was $163000.0, N/A changed from the prior year.
  • Preferred Shares reached $158000.0 in Q2 2016 per ENTA's latest filing, up from $156000.0 in the prior quarter.
  • In the past five years, Preferred Shares ranged from a high of $163000.0 in Q3 2015 to a low of $156000.0 in Q1 2016.